Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meng-Chieh Yu

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
IEEE Transactions on Bio-Medical Engineering|December 4, 2012
Multimedia-assisted breathwalk-aware systemMeng-Chieh Yu, Huan Wu, Ming-Sui Lee, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|February 1, 2013
Noncontact respiratory measurement of volume change using depth cameraMeng-Chieh Yu, Jia-Ling Liou, Shuenn-Wen Kuo, et al.
Journal of Cellular and Molecular Medicine|December 11, 2019
Lovastatin-mediated MCF-7 cancer cell death involves LKB1-AMPK-p38MAPK-p53-survivin signalling cascadeShiu-Wen Huang, I-Tsu Chyuan, Ching Shiue, et al.
British Journal of Pharmacology|June 25, 2017
WMJ-8-B, a novel hydroxamate derivative, induces MDA-MB-231 breast cancer cell death via the SHP-1-STAT3-survivin cascadeYu-Fan Chuang, Shiu-Wen Huang, Ya-Fen Hsu, et al.
Frontiers in Oncology|November 30, 2019
WMJ-S-001, a Novel Aliphatic Hydroxamate-Based Compound, Suppresses Lymphangiogenesis Through p38mapk-p53-survivin Signaling CascadeShiu-Wen Huang, Hung-Yu Yang, Wei-Jan Huang, et al.
Cells|November 10, 2023
Role of the Autism Risk Gene <i>Shank3</i> in the Development of Atherosclerosis: Insights from Big Data and Mechanistic AnalysesHsiu-Wen Chang, Ming-Jen Hsu, Li-Nien Chien, et al.
Frontiers in Pharmacology|March 17, 2018
A Novel Hydroxamate-Based Compound WMJ-J-09 Causes Head and Neck Squamous Cell Carcinoma Cell Death via LKB1-AMPK-p38MAPK-p63-Survivin CascadeChia-Sheng Yen, Cheuk-Sing Choy, Wei-Jan Huang, et al.
Biomed Research International|April 8, 2014
Trichostatin A suppresses EGFR expression through induction of microRNA-7 in an HDAC-independent manner in lapatinib-treated cellsChih-Yen Tu, Chia-Hung Chen, Te-Chun Hsia, et al.
Breast Cancer Research : BCR|November 13, 2013
Lapatinib-induced NF-kappaB activation sensitizes triple-negative breast cancer cells to proteasome inhibitorsYun-Ju Chen, Ming-Hsin Yeh, Meng-Chieh Yu, et al.
Molecular Pharmacology|January 29, 2013
Lapatinib-mediated cyclooxygenase-2 expression via epidermal growth factor receptor/HuR interaction enhances the aggressiveness of triple-negative breast cancer cellsTe-Chun Hsia, Chih-Yen Tu, Yun-Ju Chen, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
IEEE Transactions on Bio-Medical Engineering|December 4, 2012
Multimedia-assisted breathwalk-aware systemMeng-Chieh Yu, Huan Wu, Ming-Sui Lee, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|February 1, 2013
Noncontact respiratory measurement of volume change using depth cameraMeng-Chieh Yu, Jia-Ling Liou, Shuenn-Wen Kuo, et al.
Journal of Cellular and Molecular Medicine|December 11, 2019
Lovastatin-mediated MCF-7 cancer cell death involves LKB1-AMPK-p38MAPK-p53-survivin signalling cascadeShiu-Wen Huang, I-Tsu Chyuan, Ching Shiue, et al.
British Journal of Pharmacology|June 25, 2017
WMJ-8-B, a novel hydroxamate derivative, induces MDA-MB-231 breast cancer cell death via the SHP-1-STAT3-survivin cascadeYu-Fan Chuang, Shiu-Wen Huang, Ya-Fen Hsu, et al.
Frontiers in Oncology|November 30, 2019
WMJ-S-001, a Novel Aliphatic Hydroxamate-Based Compound, Suppresses Lymphangiogenesis Through p38mapk-p53-survivin Signaling CascadeShiu-Wen Huang, Hung-Yu Yang, Wei-Jan Huang, et al.
Cells|November 10, 2023
Role of the Autism Risk Gene <i>Shank3</i> in the Development of Atherosclerosis: Insights from Big Data and Mechanistic AnalysesHsiu-Wen Chang, Ming-Jen Hsu, Li-Nien Chien, et al.
Frontiers in Pharmacology|March 17, 2018
A Novel Hydroxamate-Based Compound WMJ-J-09 Causes Head and Neck Squamous Cell Carcinoma Cell Death via LKB1-AMPK-p38MAPK-p63-Survivin CascadeChia-Sheng Yen, Cheuk-Sing Choy, Wei-Jan Huang, et al.
Biomed Research International|April 8, 2014
Trichostatin A suppresses EGFR expression through induction of microRNA-7 in an HDAC-independent manner in lapatinib-treated cellsChih-Yen Tu, Chia-Hung Chen, Te-Chun Hsia, et al.
Breast Cancer Research : BCR|November 13, 2013
Lapatinib-induced NF-kappaB activation sensitizes triple-negative breast cancer cells to proteasome inhibitorsYun-Ju Chen, Ming-Hsin Yeh, Meng-Chieh Yu, et al.
Molecular Pharmacology|January 29, 2013
Lapatinib-mediated cyclooxygenase-2 expression via epidermal growth factor receptor/HuR interaction enhances the aggressiveness of triple-negative breast cancer cellsTe-Chun Hsia, Chih-Yen Tu, Yun-Ju Chen, et al.
Pageof 2